Carregant...
C‐Jun N‐terminal kinase signalling pathway in response to cisplatin
Cisplatin (cis diamminedichloroplatinum II, cDDP) is one of the most effective cancer chemotherapeutic agents and is used in the treatment of many types of human malignancies. However, inherent tumour resistance is a major barrier to effective cisplatin therapy. So far, the mechanism of cDDP resista...
Guardat en:
| Publicat a: | J Cell Mol Med |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5082413/ https://ncbi.nlm.nih.gov/pubmed/27374471 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.12908 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|